CHERYL JEFFERS: Open Payments
NPI 1144533159 · MAUMEE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,867 in 71 payments from 15 companies in 2025. Trend: 2023 $1,294 · 2024 $925 · 2025 $1,867
Food & beverage: $1,733Education: $134
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $496 |
| GlaxoSmithKline, LLC. | 19 | $282 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $240 |
| HARMONY BIOSCIENCES LLC | 5 | $189 |
| United Therapeutics Corporation | 9 | $145 |
| Regeneron Healthcare Solutions, Inc. | 3 | $143 |
| Axsome Therapeutics, Inc. | 5 | $81 |
| JAZZ PHARMACEUTICALS INC. | 3 | $71 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $41 |
| Grifols USA, LLC | 1 | $34 |
Products named: FASENRA, AIRSUPRA, OFEV, DUPIXENT, NUCALA, Tyvaso, BREZTRI, TRELEGY ELLIPTA.
Industry payments across OH — which companies pay providers there.
